Soy Intake Linked to Lower Kidney Disease Risk in Japanese Adults

Japanese adults with type 2 diabetes who ate natto, tofu, and miso soup more often showed a lower prevalence of reduced kidney function, according to a recent study published in the Journal of Diabetes Investigation.

Researchers examined data from nearly 5,000 participants in the Fukuoka Diabetes Registry to explore these dietary patterns.

The analysis linked higher isoflavone intake and frequent natto consumption to a lower prevalence of albuminuria. The evaluation was carried out by specialists from the Diabetes Center at Hakujyuji Hospital alongside the Department of Medicine and Clinical Science at Kyushu University Graduate School of Medical Sciences.

These observational findings do not establish that soy intake prevents diabetic kidney disease. The study recruited individuals receiving routine care from diabetes specialists between April 2008 and October 2010.

Researchers examined associations between soy foods and markers of kidney disease among 4,922 Japanese adults aged at least 20 years. Participants completed a brief, self-administered diet history questionnaire to assess consumption of fermented and non-fermented soybean products.

The study excluded individuals with type 1 diabetes, medication-related diabetes, current steroid use, renal replacement therapy, or serious unrelated illnesses. Blood samples measured glycated hemoglobin levels and serum markers of kidney function, including cystatin C and creatinine.

Participants who frequently consumed tofu, miso soup, and natto had a lower prevalence of decreased cystatin C-based eGFR than non-consumers. Among individuals who never ate natto, the age- and sex-adjusted prevalence of reduced kidney function reached 21.2%, compared to 9.2% for those who ate it at least once a day.

Individuals who ate natto more often additionally tended to exhibit lower body mass indices, smoke less, engage in greater physical activity, and consume higher amounts of fiber and vegetables. These associations generally persisted after further adjustment for other dietary factors, though the finding for tofu lost statistical significance.

Higher isoflavone intake linked to less frequent albuminuria and decreased eGFRcys in initial reviews. Further adjustment for dietary factors weakened the association with albuminuria, rendering it no longer statistically significant.

During a median follow-up period of five years, the composite renal outcome occurred in 424 out of 4,802 individuals. After adjusting for additional clinical and kidney-related factors, none of the associations showed a statistically significant trend over time.

The observational findings do not establish that soy intake prevents or cures diabetic kidney disease. Researchers said that fully adjusted follow-up analyses showed no significant associations with later kidney deterioration.

Scientists analyzed cross-sectional data from 4,922 Japanese adults aged at least 20 years with type 2 diabetes from the Fukuoka Diabetes Registry. Participants were recruited while receiving routine care from diabetes specialists between April 2008 and October 2010.

The study assessed fermented soybean foods like miso soup and natto, non-fermented soybean products such as tofu, and total soy isoflavones including genistein and daidzein.